Microbicide gel may prevent HIV infection in women

Scientists may be one step closer to preventing the spread of HIV infection in women. A vaginal gel containing the drug tenofovir (Viread) was shown in a clinical trial to reduce a woman’s risk of acquiring HIV during sex.

The research is an important step in protecting women from HIV infection, particularly in areas where women lack the social power to insist on the use of barrier protection such as condoms.

Read more about this revolutionary study

• Stay Up-To-Date

  1. Get the latest updates on Lifebeat news and get a sneak peak at upcoming tours and events.